Contribution of Reactive Oxygen Species to 3-Hydroxyglutarate Neurotoxicity in Primary Neuronal Cultures from Chick Embryo Telencephalons
- 1 July 2001
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 50 (1) , 76-82
- https://doi.org/10.1203/00006450-200107000-00015
Abstract
Glutaryl-CoA dehydrogenase deficiency is an autosomal recessively inherited neurometabolic disorder with a distinct neuropathology characterized by acute encephalopathic crises during a vulnerable period of brain development. 3-Hydroxyglutarate (3-OH-GA), which accumulates in affected patients, has been identified as an endogenous neurotoxin mediating excitotoxicity via N-methyl-d-aspartate receptors. As increased generation of reactive oxygen species (ROS) and nitric oxide (NO) plays an important role in excitotoxic neuronal damage, we investigated whether ROS and NO contribute to 3-OH-GA neurotoxicity. 3-OH-GA increased mitochondrial ROS generation in primary neuronal cultures from chick embryo telencephalons, which could be prevented by MK-801, confirming the central role of N-methyl-d-aspartate receptor stimulation in 3-OH-GA toxicity. ROS increase was reduced by α-tocopherol and—less effectively—by melatonin. α-Tocopherol revealed a wider time frame for neuroprotection than melatonin. Creatine also reduced neuronal damage and ROS formation but only if it was administered ≥6 h before 3-OH-GA. NO production revealed only a slight increase after 3-OH-GA incubation. NO synthase inhibitor Nω-nitro-l-arginine prevented NO increase but did not protect neurons against 3-OH-GA. The NO donor S-nitroso-N-acetylpenicillamine revealed no effect on 3-OH-GA toxicity at low concentrations (0.5–5 μM), whereas it potentiated neuronal damage at high concentrations (50–500 μM), suggesting that weak endogenous NO production elicited by 3-OH-GA did not affect neuronal viability. We conclude from our results that ROS generation contributes to 3-OH-GA neurotoxicity in vitro and that radical scavenging and stabilization of brain energy metabolism by creatine are hopeful new strategies in glutaryl-CoA dehydrogenase deficiency.Keywords
This publication has 41 references indexed in Scilit:
- Maturation-Dependent Neurotoxicity of 3-Hydroxyglutaric and Glutaric Acids In Vitro : A New Pathophysiologic Approach to Glutaryl-CoA Dehydrogenase DeficiencyPediatric Research, 2000
- Glutaric aciduria type I: Pathomechanisms of neurodegenerationJournal of Inherited Metabolic Disease, 1999
- Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing BrainScience, 1999
- The NMDA receptor subunit NR2B of neonatal rat brain: complex formation and enrichment in axonal growth conesEuropean Journal of Neuroscience, 1998
- Clinical Course, Early Diagnosis, Treatment, and Prevention of Disease in Glutaryl-CoA Dehydrogenase DeficiencyNeuropediatrics, 1996
- Modulation of Neuronal Migration by NMDA ReceptorsScience, 1993
- Glutaric Aciduria Type 1 - An Atypical Presentation Together with some Observations upon Treatment and the Possible Cause of Cerebral DamageNeuropediatrics, 1992
- Hypothesis: A Role for Quinolinic Acid in the Neuropathology of Glutaric Aciduria Type ICanadian Journal of Neurological Sciences, 1987
- Glutaric aciduria: Biochemical and morphologic considerationsThe Journal of Pediatrics, 1977
- Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and β-Hydroxyglutarate: Explanation of the symptoms in glutaric aciduria?Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976